PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30052060-8	2018	Furthermore, CYP24A1 mRNA expression in Caco2 cells was increased after demethylation treatment, and the expression of CYP24A1 induced by 1,25(OH)2D3 was significantly higher in cells treated with 5-aza-2"-deoxycytidine (DAC) than in an untreated group.	Decitabine	197-219	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	13-20	
30052060-8	2018	Furthermore, CYP24A1 mRNA expression in Caco2 cells was increased after demethylation treatment, and the expression of CYP24A1 induced by 1,25(OH)2D3 was significantly higher in cells treated with 5-aza-2"-deoxycytidine (DAC) than in an untreated group.	Decitabine	197-219	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	119-126	
24736069-8	2014	Treatment with 5-aza-2"-deoxycytidine (5-Aza) and trichostatin A (TSA) increased CYP24A1 expression in lung AC.	Decitabine	15-37	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	81-88	
24736069-8	2014	Treatment with 5-aza-2"-deoxycytidine (5-Aza) and trichostatin A (TSA) increased CYP24A1 expression in lung AC.	Decitabine	39-44	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	81-88	
24736069-11	2014	Treatment with TSA increased H3K4me2 and H3K9ac and simultaneously decreased H3K9me2 at the CYP24A1 promoter and treatment with 5-Aza and/or TSA increased the recruitment of vitamin D receptor (VDR) to vitamin D response elements (VDRE) of the CYP24A1 promoter.	Decitabine	128-133	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	92-99	
24736069-11	2014	Treatment with TSA increased H3K4me2 and H3K9ac and simultaneously decreased H3K9me2 at the CYP24A1 promoter and treatment with 5-Aza and/or TSA increased the recruitment of vitamin D receptor (VDR) to vitamin D response elements (VDRE) of the CYP24A1 promoter.	Decitabine	128-133	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	244-251	
22940288-6	2013	Methyltransferase inhibitor 5-aza-2"-deoxycytidine (DAC) treatment resulted in an over 50-fold induction of CYP24A1 mRNA expression in Coga1A and HT-29 cells but in no response in Caco2/AQ and Coga13 cells.	Decitabine	28-50	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	108-115	
20587525-3	2010	Treatment with the DNA methyltransferase inhibitor 5-aza-2"-deoxycytidine (DAC) activates CYP24A1 expression in prostate cancer cells.	Decitabine	51-73	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	90-97	
20587525-3	2010	Treatment with the DNA methyltransferase inhibitor 5-aza-2"-deoxycytidine (DAC) activates CYP24A1 expression in prostate cancer cells.	Decitabine	75-78	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	90-97	
20587525-8	2010	ChIP-qPCR assay reveals that treatment with DAC and TSA increases the recruitment of vitamin D receptor to the CYP24A1 promoter.	Decitabine	44-47	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	111-118	
15860259-5	2005	Treatment of PNT-2 cells with the methylation inhibitor 5-aza-2"-deoxycytidine together with the deacetylation inhibitor trichostatin A resulted in elevation of both CYP27B1 and CYP24 mRNA expression demonstrating that even in normal human prostate cells expression of Vitamin D hydroxylases may be under epigenetic control.	Decitabine	56-78	cytochrome P450 family 24 subfamily A member 1	Homo sapiens	178-183